Seroepidemiologic Studies
"Seroepidemiologic Studies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases.
| Descriptor ID |
D016036
|
| MeSH Number(s) |
E05.318.760.500.950 N05.715.360.775.175.800 N06.850.520.450.500.950
|
| Concept/Terms |
Seroepidemiologic Studies- Seroepidemiologic Studies
- Studies, Seroepidemiologic
- Seroepidemiological Study
- Seroepidemiological Studies
- Studies, Seroepidemiological
- Study, Seroepidemiological
- Seroepidemiologic Study
- Study, Seroepidemiologic
|
Below are MeSH descriptors whose meaning is more general than "Seroepidemiologic Studies".
Below are MeSH descriptors whose meaning is more specific than "Seroepidemiologic Studies".
This graph shows the total number of publications written about "Seroepidemiologic Studies" by people in this website by year, and whether "Seroepidemiologic Studies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2017 | 0 | 2 | 2 |
| 2019 | 0 | 4 | 4 |
| 2020 | 0 | 3 | 3 |
| 2021 | 0 | 5 | 5 |
| 2022 | 0 | 9 | 9 |
| 2023 | 0 | 4 | 4 |
| 2024 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Seroepidemiologic Studies" by people in Profiles.
-
Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status. Int J Cancer. 2024 Jul 15; 155(2):251-260.
-
Household transmission of SARS-CoV-2 in a rural area in South Africa. S Afr Med J. 2024 Feb 13; 114(2):e1159.
-
Incidence and epidemiology of conjunctival squamous cell carcinoma in relation to the HIV epidemic in South Africa: a 25-year analysis of the National Cancer Registry (1994-2018). Br J Ophthalmol. 2024 01 29; 108(2):175-180.
-
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus. N Engl J Med. 2023 Jul 20; 389(3):215-227.
-
Knowledge, attitudes, practices and intention to get vaccinated against COVID-19: results from a cross-sectional survey in three peri-urban communities in South Africa. Pan Afr Med J. 2023; 45:120.
-
Sustained Low Incidence of Severe and Fatal COVID-19 Following Widespread Infection Induced Immunity after the Omicron (BA.1) Dominant in Gauteng, South Africa: An Observational Study. Viruses. 2023 02 21; 15(3).
-
Kaposi sarcoma-associated herpesvirus, HIV-1 and Kaposi sarcoma risk in black South Africans diagnosed with cancer during antiretroviral treatment rollout. Int J Cancer. 2023 05 15; 152(10):2081-2089.
-
Molecular characterization and genotyping of hepatitis C virus from Sudanese end-stage renal disease patients on haemodialysis. BMC Infect Dis. 2022 Nov 14; 22(1):848.
-
High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa. Int J Infect Dis. 2022 Dec; 125:241-249.
-
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa. Trop Med Int Health. 2022 Jun; 27(6):564-573.